Picture of Genscript Biotech logo

1548 — Genscript Biotech News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeLarge CapNeutral

Brief: Duke-Nus And Genscript Announce Notice Of Allowance For U.S. Patent Application For Sars-Cov-2 Surrogate Virus Neutralization Test

June 21 (Reuters) - Genscript Biotech Corp  1548.HK :
    * DUKE-NUS AND GENSCRIPT ANNOUNCE NOTICE OF ALLOWANCE FOR
U.S.
PATENT APPLICATION FOR SARS-COV-2 SURROGATE VIRUS NEUTRALIZATION
TEST

Source text for Eikon:  ID:nPn5Q3Qpga 
Further company coverage:  1548.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Genscript Biotech

See all news